Senator Spilka to Receive BIO 2012 State Legislator of the Year Award
(BOSTON) – On Monday, June 18, 2012 Senator Karen Spilka will be recognized by the Biotechnology Industry Organization (BIO) as one of their State Legislators of the Year at the 2012 BIO International Convention being held next week at the Boston Convention & Exhibition Center.
The Massachusetts Biotechnology Council and local life science leaders nominated Spilka for the award and she was selected as a recipient by a vote of BIO’s State Government Relations Committee.
Spilka, who serves as the Senate Chair of the BioTech Legislative Caucus, is being recognized for her dedicated work to advance the biotechnology industry, her support of the issues important to the industry, and her efforts to attract and retain life science companies in Massachusetts. Through her active work to ensure economic development initiatives take into account the medical technology industry, Spilka has helped foster a pro-business and pro-biotechnology environment in the Commonwealth.
The award ceremony is scheduled to take place at the Massachusetts Pavilion at the Convention. The theme of this year’s Pavilion – Lifecycle Massachusetts – illustrates how Massachusetts life sciences organizations span the spectrum of healthcare. From training and education, through research and discovery, and right through to manufacturing and delivery of treatment – this lifecycle is possible thanks to the unique collaboration of all stakeholders in the state’s biotechnology supercluster, including government.
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers, and related organizations across the country and in more than 30 other nations. Members are involved in the research and development of innovative healthcare, agricultural, industrial, and environmental biotechnology products.
The BIO International Convention features hundreds of sessions covering biotech trends, policy issue and technological innovations, and the world’s largest biotechnology exhibition. Over 15,500 attendees from more than 60 countries, including numerous U.S. officials and foreign dignitaries, are expected to attend.